Sunday, February 25, 2018
Redactor's Choice
You are here: Home / Tag: acquisition

Tag: acquisition

Forbes Media Acquires UK Online Publication, The Memo

memo.jpg_width.960

Forbes Media announced today the acquisition of the British online business publication, The Memo, for an undisclosed amount. The deal will result in the founding of the first full-fledged editorial team that’s focused on European content, with The Memo’s Founder and Editor, Alex Wood, taking on the role as European Editor. The acquisition of The Memo is part of the company’s wider expansion plans in Europe and will enable the publisher to strengthen its presence in Europe and its European content on Forbes.com. Forbes will look to further e... Read More »

Pfizer Launches Zavicefta™ (ceftazidime-avibactam) In The U.K. And Germany, A New Antibiotic To Treat Complicated Infections Caused By Gram-Negative Bacteria

Pfizer_logo

In June 2016, the European Medicines Agency (EMA) approved the marketing authorization for Zavicefta based on an extensive clinical trial program. Zavicefta is indicated for the treatment of adults with complicated intra-abdominal infection (cIAI), complicated urinary tract infection (cUTI) and Hospital-Acquired Pneumonia (HAP), including Ventilator Associated Pneumonia (VAP). Zavicefta is also indicated for the treatment of infections due to aerobic Gram-negative organisms in adult patients with limited treatment options. Zavicefta addresses P... Read More »

Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca

Pfizer_logo

“The addition of AstraZeneca’s complementary small molecule anti-infectives portfolio enhances our global expertise and offerings in an increasingly important area of therapeutics that addresses the public health needs of patients and healthcare professionals. Additionally this acquisition is an example of how we are focusing our investments to drive sustainable revenue growth potential for our Essential Health business,” said John Young, group president, Pfizer Essential Health. About the acquired assets Product Indica... Read More »

Pfizer Completes Acquisition of Medivation

Pfizer_logo

“Pfizer and Medivation are now one unified team combining research and resources to combat cancer. This acquisition represents a rare opportunity to expand our business offering with an attractive pipeline and with XTANDI, an important medicine for men with prostate cancer. We welcome our new Medivation colleagues to the team and look forward to continuing the successful partnership with Astellas for XTANDI,” said Albert Bourla, group president, Pfizer Innovative Health. “Given the breadth of Pfizer’s existing oncology portfolio and emerging im... Read More »

Pfizer Completes Acquisition of Anacor

Pfizer_logo

“Now that Anacor is part of Pfizer, we can accelerate our shared commitment to help patients with inflammatory disease, an area of high unmet medical need,” said Albert Bourla, Group President, Pfizer Innovative Health. “We believe that Pfizer is in a position to quickly capitalize on the benefits offered by the combination with Anacor, including the potential for a near-term U.S. product launch and subsequent commercialization of crisaborole, a differentiated asset with compelling clinical data. If approved, crisaborole has the potential to be... Read More »

Bayer Confirms Preliminary Discussion Regarding Acquisition of Monsanto

bayer-cross-in-shanghai-1024x512

The proposed combination would reinforce Bayer as a global innovation-driven Life Science company with leadership positions in its core segments, and would create a leading integrated agriculture business. This statement follows Monsanto’s announcement earlier today regarding a proposal from Bayer. A further statement will be made as appropriate. Bayer: Science For A Better Life Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefi... Read More »

Boskalis subsidiary Smit Lamnalco acquires Australian towage company

certificate

PB Towage is the second largest player in Australia with activities along the Eastern coast stretching from Melbourne to the Cape York Peninsula. Following this transaction, Smit Lamnalco will be active in 8 ports in Australia with a total of 29 vessels offering a combination of harbour towage, terminal and FPSO-related services. The acquisition follows the Boskalis strategy to develop its position in the towage market through partnerships such as Smit Lamnalco and to grow through regional consolidation opportunities. For Smit Lamnalco, this... Read More »

Reed Elsevier announces proposed acquisition of FircoSoft

handshake

Reed Elsevier intends that FircoSoft will be combined with Accuity, its leading provider of global payment routing data and anti-money laundering solutions to banks and businesses worldwide. “The combination of FircoSoft and Accuity will bring best-in-class solutions that will enable customers to achieve their sanctions screening, Anti-Money Laundering and Know Your Customer requirements with a level of precision and efficiency that has never been experienced before,” says Hugh Jones, President and CEO of Accuity. FircoSoft is currently o... Read More »

Vitol completes acquisition of Shell’s Australian downstream business; launches Viva Energy Australia

certificate

Viva Energy comprises Shell’s Geelong refinery and 870-site retail business, along with its bulk fuels, bitumen, chemicals and part of its lubricants businesses in Australia. Viva Energy will be the exclusive distributor of Shell branded fuels and lubricants in Australia. The majority of Shell’s downstream staff in Australia will remain with Viva Energy. In February 2014, Vitol announced it had reached a binding agreement with Shell to acquire its Australian downstream business (excluding Aviation) for a total consideration of A$2.9 billion ... Read More »

DSM to acquire Aland (China) to strengthen vitamin C position

orange

Acquiring Aland, one of the leading Vitamin C manufacturers in China, allows DSM to further strengthen its position in vitamin C. Aland increases DSM’s global footprint in vitamins for Human Nutrition & Health, Animal Nutrition & Health and Personal Care. DSM remains fully committed to its current vitamin C manufacturing facility in Dalry (Scotland, United Kingdom). The acquisition fully meets DSM’s financial and strategic requirements. Aland was founded in 1990 and has a production facility in Jingjiang, Jiangsu Province in China. I... Read More »

Scroll To Top